ABCL - Abcellera Biologics  - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ABCL is currently covered by 8 analysts with an average price target of $16.38. This is a potential upside of $12.33 (304.44%) from yesterday's end of day stock price of $4.05.

Abcellera Biologics 's activity chart (see below) currently has 19 price targets and 31 ratings on display. The stock rating distribution of ABCL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 9.18% with an average time for these price targets to be met of 19.43 days.

Highest price target for ABCL is $28, Lowest price target is $8, average price target is $16.38.

Most recent stock forecast was given by ROBERT WASSERMAN from BENCHMARK on 22-Feb-2024. First documented stock forecast 05-Jan-2021.

Best performing analysts who are covering ABCL - Abcellera Biologics :

Puneet Souda Do Kim Tiago Fauth Gary Nachman Andrea Tan Robert Wasserman Scott Schoenhaus

Currently out of the existing stock ratings of ABCL, 18 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

12

1 months 27 days ago

0/2 (0%)

$6.55 (120.18%)

Buy

8

$3.51 (78.17%)

6

3 months 13 days ago

0/2 (0%)

$2.16 (36.99%)

Buy

22

$17.51 (389.98%)

32

5 months 15 days ago

0/3 (0%)

$17.3 (368.09%)

Buy

24

$19.51 (434.52%)

30

8 months 14 days ago

0/2 (0%)

$17.96 (297.35%)

Buy

28

$23.51 (523.61%)

34

11 months 13 days ago

1/6 (16.67%)

$22.01 (367.45%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABCL (Abcellera Biologics ) average time for price targets to be met?

On average it took 19.43 days on average for the stock forecasts to be realized with a an average price target met ratio 9.18

Which analyst has the current highest performing score on ABCL (Abcellera Biologics ) with a proven track record?

PUNEET SOUDA

Which analyst has the current lower performing score on ABCL (Abcellera Biologics ) with a proven track record?

SCOTT SCHOENHAUS

Which analyst has the most public recommendations on ABCL (Abcellera Biologics )?

Puneet Souda works at LEERINK and has 17 price targets and 9 ratings on ABCL

Which analyst is the currently most bullish on ABCL (Abcellera Biologics )?

Tiago Fauth with highest potential upside - $23.51

Which analyst is the currently most reserved on ABCL (Abcellera Biologics )?

Robert Wasserman with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?